Read twice and referred to the Committee on the Judiciary.
Last progress October 30, 2025 (4 months ago)
Introduced on October 30, 2025 by David Harold McCormick
Permanently places a class of powerful synthetic opioids known as 2-benzylbenzimidazole opioids (commonly called nitazenes) into Schedule I of the Controlled Substances Act by defining the class by chemical structure, opioid activity, and named examples. Any such compounds that were temporarily scheduled become permanently Schedule I, and the law clarifies that research or handling of these substances still requires proper DEA registration and compliance with existing research pathways.